All-trans-retinoic acid modulates glycolysis via H19 and telomerase: The role of mir-let-7a in estrogen receptor-positive breast cancer cells

Breast cancer (BC) is the most commonly diagnosed cancer in women. Treatment approaches that differ between estrogen-positive (ER+) and triple-negative BC cells (TNBCs) and may subsequently affect cancer biomarkers, such as H19 and telomerase, are an emanating delight in BC research.